In last trading session, Apogee Therapeutics Inc (NASDAQ:APGE) saw 0.44 million shares changing hands with its beta currently measuring 1.54. Company’s recent per share price level of $40.62 trading at -$0.02 or -0.05% at ring of the bell on the day assigns it a market valuation of $2.42B. That closing price of APGE’s stock is at a discount of -56.33% from its 52-week high price of $63.50 and is indicating a premium of 35.5% from its 52-week low price of $26.20. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.66 million shares which gives us an average trading volume of 720.75K if we extend that period to 3-months.
Apogee Therapeutics Inc (NASDAQ:APGE) trade information
Upright in the red during last session for losing -0.05%, in the last five days APGE remained trading in the green while hitting it’s week-highest on Friday, 05/16/25 when the stock touched $40.62 price level, adding 3.77% to its value on the day. Apogee Therapeutics Inc’s shares saw a change of -10.33% in year-to-date performance and have moved 8.93% in past 5-day. Apogee Therapeutics Inc (NASDAQ:APGE) showed a performance of 26.78% in past 30-days. Number of shares sold short was 10.38 million shares which calculate 14.24 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 95 to the stock, which implies a rise of 57.24% to its current value. Analysts have been projecting 95 as a low price target for the stock while placing it at a high target of 95. It follows that stock’s current price would drop -133.87% in reaching the projected high whereas dropping to the targeted low would mean a loss of -133.87% for stock’s current value.
Apogee Therapeutics Inc (APGE) estimates and forecasts
In 2025, company’s earnings growth rate is likely to be around -33.60% while estimates for its earnings growth in next 5 years are of -21.59%.
Apogee Therapeutics Inc (NASDAQ:APGE)’s Major holders
Insiders are in possession of 7.63% of company’s total shares while institution are holding 137.59 percent of that, with stock having share float percentage of 148.95%. Investors also watch the number of corporate investors in a company very closely, which is 137.59% institutions for Apogee Therapeutics Inc that are currently holding shares of the company. VR ADVISER, LLC is the top institutional holder at APGE for having 8.49 million shares of worth $334.21 million. And as of 2024-06-30, it was holding 15.0284 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 7.51 million shares on 2024-06-30. The number of shares represents firm’s hold over 13.2812 of outstanding shares, having a total worth of $295.36 million.
On the other hand, VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025 , the former fund manager was holding 2.0 shares of worth $81.24 million or 4.34% of the total outstanding shares. The later fund manager was in possession of 1.41 shares on Mar 31, 2025 , making its stake of worth around $57.13 million in the company or a holder of 3.05% of company’s stock.
